Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome. [electronic resource]
Producer: 20180326Description: 1839-1845 p. digitalISSN:- 1473-5571
- Alemtuzumab -- administration & dosage
- Anti-Retroviral Agents -- therapeutic use
- Antineoplastic Agents, Immunological -- administration & dosage
- CD4-Positive T-Lymphocytes -- virology
- DNA, Viral -- analysis
- Flow Cytometry
- HIV -- isolation & purification
- HIV Infections -- complications
- Humans
- Immunophenotyping
- Male
- Middle Aged
- Sezary Syndrome -- drug therapy
- Skin Neoplasms -- drug therapy
- T-Lymphocyte Subsets -- immunology
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.